In conclusion, our study demonstrates that SLAMF8 and NINJ2 are key drivers of neuroinflammation and oxidative stress in Alzheimer’s disease by activating the TLR4/NF-κB pathway. Here, SLAMF8 is linked to Alzheimer disease.